Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CHKA | P35790 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1750930 | 0.97 | HTT (0.38) | ACHEHTTLMNAALDH1A1TDP1 | |
| SCHEMBL16183106 | 0.79 | NFE2L2 (0.48) | ALDH1A1KDM4ESMN1; SMN2CA1 | |
| SCHEMBL22953081 | 0.79 | SLC22A2 (0.38) | HTTLMNAALDH1A1KDM4ESMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3381181 | 0.77 | PABPC1 (0.37) | HTTLMNAALDH1A1KDM4ESMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL9358685 | 0.76 | HTT (0.40) | ACHEHTTLMNAALDH1A1TDP1 | |
| SCHEMBL5325200 | 0.74 | TYR (0.37) | HTTLMNAALDH1A1KDM4E | |
| Hydrochloric Acid SCHEMBL20507847 | 0.74 | HTT (0.35) | ACHEHTTLMNAALDH1A1TDP1 | |
| SCHEMBL1171636 | 0.72 | KDM4E (0.38) | ACHEHTTLMNAALDH1A1TDP1 | |
| SCHEMBL5287705 | 0.72 | TP53 (0.43) | LMNAALDH1A1TDP1SMN1; SMN2TSHR | |
| SCHEMBL20382822 | 0.70 | SLC6A4 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11996557-B2 | Direct regeneration of lithium ion cathodes by ionothermal relithiation | UT-BATTELLE, LLC (US) | 2024-05-28 | — | — | US | disclosed |
| US-11795583-B2 | Plasticized melt spinning process using ionic liquids for production of polyacrylonitrile fibers | UT-BATTELLE, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230246229-A1 | ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES | Octet Scientific, Inc. | 2023-08-03 | — | — | US | disclosed |
| US-20220376240-A1 | DIRECT REGENERATION OF LITHIUM ION CATHODES BY IONOTHERMAL RELITHIATION | U. S. DEPARTMENT OF ENERGY | 2022-11-24 | — | — | US | disclosed |
| US-20220235493-A1 | PLASTICIZED MELT SPINNING PROCESS USING IONIC LIQUIDS FOR PRODUCTION OF POLYACRYLONITRILE FIBERS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2022-07-28 | — | — | US | disclosed |
| US-11251433-B2 | Nitrogen-sulfur-carbon nanocomposites and their application as cathode materials in lithium-sulfur batteries | UT-BATTELLE, LLC (US) | 2022-02-15 | — | — | US | disclosed |
| US-20220024899-A1 | BI-FUNCTIONAL NANOHYBRIDS | SON (FR) | 2022-01-27 | — | — | US | disclosed |
| EP-3669978-A1 | BI-FUNCTIONAL NANOHYBRIDS | Université de Bourgogne (FR) | 2020-06-24 | — | — | EP | disclosed |
| US-20180309130-A1 | NITROGEN-SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES | UT-BATTELLE, LLC (US) | 2018-10-25 | — | — | US | disclosed |
| US-8835466-B2 | Synthesis and uses of pyroglutamic acid derivatives | PRODIMED, S.A. (ES) | 2014-09-16 | — | — | US | disclosed |
| US-8084617-B2 | Ionic liquids having fluoroalkyltrifluoroborate anions | MERCK PATENT GMBH (DE) | 2011-12-27 | — | — | US | disclosed |
| US-7671206-B2 | Synthesis and uses of pyroglutamic acid derivatives | PRODIMED, S.A. (ES) | 2010-03-02 | — | — | US | disclosed |
| US-20090163555-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | PRODIMED, S.A. (ES) | 2009-06-25 | — | — | US | disclosed |
| WO-2008054866-A2 | METHOD OF MAKING ORDERED NANOSTRUCTURED LAYERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-05-08 | — | — | WO | disclosed |
| US-20070249678-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | PRODIMED, S.A. (ES) | 2007-10-25 | — | — | US | disclosed |
| US-20070213538-A1 | Ionic Liquids Having Fluoroalkyltrifluoroborate Anions | MERCK PATENT GMBH (DE) | 2007-09-13 | — | — | US | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
| EP-1730157-A1 | IONIC LIQUIDS COMPRISING FLUORALKYLTRIFFLUOROBORATE ANIONS | MERCK PATENT GmbH (DE) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005105815-A1 | IONIC LIQUIDS COMPRISING FLUORALKYLTRIFFLUOROBORATE ANIONS | MERCK PATENT GMBH (DE) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249678-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | GLUL, RIMKLA, PHKG1 | ACHE 4329/4885HTT 743/4885LMNA 2747/4885 |
| US-20220024899-A1 | BI-FUNCTIONAL NANOHYBRIDS | MPO, DNMT1, CAT | ACHE 244/4885HTT 4349/4885LMNA 3381/4885 |
| US-20070213538-A1 | Ionic Liquids Having Fluoroalkyltrifluoroborate Anions | AFF1, AFF2, AFF4 | ACHE 4409/4885HTT 1452/4885LMNA 998/4885 |
| US-20090163555-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | GLUL, RIMKLA, GLS | ACHE 4188/4885HTT 1655/4885LMNA 2619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.